E-LIB Suche - Ergebnisse für: Durrington, P

1

Cardiovascular disease incidence in 21 years follow-up in s..:

Iyen, B. ; Qureshi, N. ; Roderick, P....
Atherosclerosis. 315 (2020) - p. e39 , 2020

Link: https://doi.org/10.1016/..

2

Characteristics and cardiovascular disease morbidity of men..:

Iyen, B. ; Qureshi, N. ; Roderick, P....
Atherosclerosis. 315 (2020) - p. e77 , 2020

Link: https://doi.org/10.1016/..

3

Coronary heart disease mortality in severe and non-severe f..:

Humphries, S. ; Cooper, J. ; Capps, N....
Atherosclerosis. 287 (2019) - p. e89 , 2019

Link: https://doi.org/10.1016/..

4

Variation And Distribution Of Apolipoprotein E And Its Glyc..:

Liu, Y. ; Dhage, S. ; France, M....
Atherosclerosis. 287 (2019) - p. e236 , 2019

Link: https://doi.org/10.1016/..

5

Changes In Serum Triglycerides Are Associated With Improvem..:

Adam, S. ; Azmi, S. ; Liu, Y....
Atherosclerosis Supplements. 38 (2019) - p. e3 , 2019

Link: https://doi.org/10.1016/..

6

The importance of considering LDL-C response as well as car..:

Soran, H. ; Durrington, P.
Atherosclerosis. 235 (2014) 2 - p. e300 , 2014

Link: https://doi.org/10.1016/..

7

(6) In statin treated patients, high hdl paraoxonase-1 acti..:

Yadav, R. ; Soran, H. ; France, M....
Atherosclerosis. 223 (2012) 2 - p. 529 , 2012

Link: https://doi.org/10.1016/..

8

(5) High paraoxonase-1 hdl is more effective than low parao..:

Hama, S. ; Soran, H. ; Albeck, S....
Atherosclerosis. 223 (2012) 2 - p. 529 , 2012

Link: https://doi.org/10.1016/..

9

A gene variant near ATM is significantly associated with me..:

van Leeuwen, N. ; Nijpels, G. ; Becker, M. L....
Diabetologia. 55 (2012) 7 - p. 1971-1977 , 2012

Link: https://doi.org/10.1007/..

10

63 INFLUENCE OF THE GLUCOSE TOLERANCE TEST ON PRO-ATHEROGEN..:

Soran, H. ; Charlton-Menys, V. ; Younis, N....
Atherosclerosis Supplements. 12 (2011) 1 - p. 15 , 2011

Link: https://doi.org/10.1016/..

11

231 ASSESSMENT OF 2 METHODS FOR ISOLATION OF HIGH-DENSITY L..:

Hama, S. ; Soran, H. ; Charlton-Menys, V....
Atherosclerosis Supplements. 12 (2011) 1 - p. 51 , 2011

Link: https://doi.org/10.1016/..

12

258 LIPID PROFILE IN PATIENTS WITH INFLAMMATORY POLYARTHRIT..:

Alhusain, A.Z. ; Verstappen, S.M. ; Mirjafari, H....
Atherosclerosis Supplements. 12 (2011) 1 - p. 56 , 2011

Link: https://doi.org/10.1016/..

13

ESC/EAS Guidelines for the management of dyslipidaemias: Th..:

Developed with the special contribution of: European Association for Cardiovascular Prevention & Rehabilitation ; Reiner, Z. ; Catapano, A. L....
European Heart Journal. 32 (2011) 14 - p. 1769-1818 , 2011

Link: https://doi.org/10.1093/..

14

230 CHANGES IN FUNCTION AND STRUCTURE OF HIGH-DENSITY LIPOP..:

Hama, S. ; Soran, H. ; Liu, Y....
Atherosclerosis Supplements. 12 (2011) 1 - p. 50 , 2011

Link: https://doi.org/10.1016/..

15

625 HIGH-DOSE ATORVASTATIN REDUCES APOLIPOPROTEIN E CONCENT..:

Liu, Y. ; Soran, H. ; Charlton-Menys, V....
Atherosclerosis Supplements. 12 (2011) 1 - p. 132 , 2011

Link: https://doi.org/10.1016/..